Toggle Menu
Join our Community
Support ToI and remove
all
ads
Learn more
English
Français
עברית
Get The Daily Edition
Account
Sign In
Sign in
Join our Community
Open Search form
Toggle Menu
Israel & the Region
Jewish Times
Israel Inside
Tech Israel
Real Estate
Israel
The Blogs
Podcasts
Video
Newsletters
The Daily Edition
What Matters Most Today
Tech Israel
Updates from Silicon Wadi
Real Estate Israel
Monthly Update
The Weekend Edition
The Best Reads of the Week
Weekly Highlights
Choice Voices From The Blogs
Partners
Atlanta
Atlanta Jewish Times
North New Jersey
The Jewish Standard
Pittsburgh
Jewish Chronicle
United Kingdom
The Jewish News
Australia
The Australian Jewish News
For Publishers
Become a Partner
Open Search form
Toggle Menu
search
Input search
Clear search input
English
Français
עברית
Latest Articles
Latest Alerts
Israel & the Region
Jewish Times
Israel Inside
Tech Israel
Real Estate
Israel
The Blogs
Podcasts
Video
Newsletters
The Daily Edition
What Matters Most Today
Tech Israel
Updates from Silicon Wadi
Real Estate Israel
Monthly Update
The Weekend Edition
The Best Reads of the Week
Weekly Highlights
Choice Voices From The Blogs
Partners
Atlanta
Atlanta Jewish Times
North New Jersey
The Jewish Standard
Pittsburgh
Jewish Chronicle
United Kingdom
The Jewish News
Australia
The Australian Jewish News
For Publishers
Become a Partner
Community
Join our community
Sign in
About The Times of Israel
Advertise on The Times of Israel
Contact us
Download our App
For IOS users
For Android users
Get the Daily Edition
submit
Follow us
© 2026 The Times of Israel , All Rights Reserved
Terms and conditions
Privacy policy
Input search
Clear search input
×
Paul RICARD
May 8, 2021, 6:44 am
Ibuprofen does not worsen COVID-19 symptoms — study
At start of pandemic there was concern over potential effects of anti-inflammatory drugs on illness; most extensive research yet appears to rule out any issues
By
Paul RICARD
April 14, 2021, 2:29 am
What we know as clot fears hamper rollout of J&J, AstraZeneca vaccines
The two shots, based on same technology, suspected of causing very rare but serious blood clots in a handful of cases among millions vaccinated
By
Paul RICARD
January 13, 2021, 4:26 pm
South African virus mutation raises questions over vaccine effectiveness
Scientists express concern over E484K strain, which Cambridge microbiologist warns ‘could be the start of problems for spike vaccines’ developed by Pfizer, Moderna
By
Paul RICARD
December 14, 2020, 7:16 pm
Risks vs. benefits: What we know about COVID-19 vaccines and their side effects
While fatigue, headaches and muscle pain can be expected, clinical trials have shown that more serious reactions to inoculations are few and far between
By
Paul RICARD
September 26, 2020, 3:07 am
Do masks not only shield against virus, but also help boost immunity?
Unproven hypothesis suggests face coverings expose some wearers to small doses of coronavirus, sparking immune response, but not serious illness
By
Paul RICARD
September 9, 2020, 11:34 pm
In race for coronavirus vaccine, safety trumps speed
Experts say pausing of phase 3 trials for top vaccine candidate after volunteer develops unexplained illness is ‘a totally reasonable measure of caution’ — but markets are spooked
By
Paul RICARD
and
Issam Ahmed
May 30, 2020, 3:30 pm
Scientist posits ‘wild’ hypothesis that cross immunity could slow pandemic
WHO expresses caution on whether there may be protection from prior exposure to some cold viruses; scientists examine if some people are more vulnerable to infection than others
By
Paul RICARD
March 25, 2020, 10:45 pm
Test shortages in many countries hamper mass virus screening goals
South Korea and Singapore successfully curb cases with aggressive testing strategy, but European nations focused more on those entering hospitals
By
Paul RICARD
April 2, 2018, 2:45 am
New bodily ‘organ’ discovered; may play role in spread of cancer
Finding of interstitium has potential to drive dramatic advances in medicine, researchers say
By
Paul RICARD
and
Marlowe HOOD
Load More
Advertisement
close popup
Sign in or Join The Times of Israel Community
Paying ToI Community members are invited to comment on articles
Email address
*
Please use the following structure: example@domain.com
Continue
Or Continue with
By joining you agree to the
terms and conditions
back
close popup
Register to continue
Email address
*
Change
REGISTER
Or Continue with
back
close popup
Log in to continue
Email address
*
Something went wrong.
Please try again in a few minutes..
Continue
back
close popup
Sign in or Join The Times of Israel Community
You are currently registered. Please join The Times of Israel Community to comment and enjoy other Community benefits
Only ToI Community members can comment below articles
Email address
*
Password
*
Incorrect password. Please try again or choose an option below.
Forgot your password?
/
Send me a login link
Continue
Sign in without joining
Or Continue with
close popup
Check your email
We sent an email to you at
.
It has a link that will sign you in.
Click the link in that email to complete registration so you can comment.
back
close popup
Join The Times of Israel Community
Commenting is available for paying members of The Times of Israel Community only. Please join our Community to comment and enjoy other Community benefits.
Email address
*
Please use the following structure: example@domain.com
JOIN NOW!
close popup
Thank you! Now check your email
You are now a member of The Times of Israel Community! We sent you an email with a login link to
. Once you're set up, you can start enjoying Community benefits and commenting.
Back to top
Never miss breaking news on Israel
Get notifications to stay updated
Stay updated
No thanks
You're subscribed
close popup
Register for free
and continue reading
Registering allows you to manage your newsletters and alerts and helps us improve your experience. It takes just a few seconds.
Already registered? Enter your email to sign in.
Email address
Please use the following structure: example@domain.com
REGISTER OR SIGN IN
Or Continue with
By registering you agree to the
terms and conditions
. Once registered, you’ll receive our Daily Edition email for free.
Send me The Times of Israel Daily Edition
back
close popup
Register to continue
Email address
Change
REGISTER
Or Continue with
back
close popup
Log in to continue
Email address
Something went wrong.
Please try again in a few minutes..
Continue
back
close popup
Sign in or Register
Email address
*
Password
*
Incorrect password. Please try again or choose an option below.
Continue
I forgot my password
/
Send me a sign in link
Or Continue with
back
close popup
Check your email
We sent an email to you at
.
It has a link that will sign you in.
Click the link in that email to complete your registration.